Hilvo, Mika http://orcid.org/0000-0003-0663-5843
Salonurmi, Tuire
Havulinna, Aki S.
Kauhanen, Dimple
Pedersen, Eva Ringdal
Tell, Grethe S.
Meyer, Klaus
Teeriniemi, Anna-Maria
Laatikainen, Tiina
Jousilahti, Pekka
Savolainen, Markku J.
Nygård, Ottar
Salomaa, Veikko
Laaksonen, Reijo
Funding for this research was provided by:
Suomen Akatemia
City of Oulu
Diabetesliitto
Juho Vainion Säätiö
Sigrid Juséliuksen Säätiö
Sydäntutkimussäätiö
Sosiaali- ja Terveysministeriö
Article History
Received: 31 October 2017
Accepted: 12 February 2018
First Online: 15 March 2018
Duality of interest
: Zora Biosciences Oy holds patents for the diagnostic use of ceramides for cardiovascular risk determination. MH and DK are employees, and RL is an employee and shareholder, of Zora Biosciences Oy. VS participated in a congress trip sponsored by Novo Nordisk.